Nutreva S.A.S.   Report issue

For profit Phase 4
Founded: Medellin Colombia (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2012
NCT01791608
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

amino acids (Freamine) (1 trial)

zinc dichloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 4)

Infections (Phase 4)

Respiratory Tract Infections (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2